Summary
Blast cell populations from 32 patients with acute non-lymphoblastic leukaemia of various morphological types have been examined for their ability to stimulate allogeneic T lymphocytes from normal donors in one-way mixed leucocyte culture (MLC). At the same time, these leukaemic cell populations were examined for the amounts of major histocompatibility complex Class I and Class II antigens they expressed, and their ability to release interleukin 1 (IL1) in culture both with and without stimulation by lipopolysaccharide. The abilities of the leukaemic cell populations to stimulate in MLC, and to produce IL1, were found to be associated with the expression of morphological characteristics of monocytic differentiation, and correlated significantly. In contrast, no correlation was observed between the extent of Class I or Class II expression and MLC stimulatory ability. Many myeloblast populations of immature phenotype were unable to stimulate allogeneic T cells despite their strong expression of these antigens. This lack of stimulatory ability was not overcome by the addition of exogenous IL1. We therefore conclude that the correlation between the production of IL1 and MLC stimulatory ability does not necessarily imply a cause/effect relationship, and that the interaction between allo-antigen and the T cell receptor together with a supply of lymphokine ‘co-stimulator’ is not sufficient to activate resting T lymphocytes. The failure of some Class I and II antigen positive leukaemic blasts to stimulate in MLC even in the presence of exogenous IL1 may be due to the lack of other differentiation-associated cell surface molecules necessary for stable cell-cell interaction.
Similar content being viewed by others
References
Abo T, Balch CM (1981) A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 127:1024–1029
Allavena P, Scala G, Djeu JY, Procopio AD, Oppenheim JJ, Herberman RB, Ortaldo JR (1985) Production of multiple cytokines by clones of human large granular lymphocytes. Cancer Immunol Immunother 19:121–126
Ashman LK (1983) Stimulatory ability of human leukaemic cells in the allogeneic mixed leucocyte reaction. Aust J Exp Biol Med Sci 61:477–488
Ashman LK (1984) Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate. Cell Immunol 87:613–625
Ashman LK (1987) The immunogenicity of tumour cells. Immunol Cell Biol 65:271–277
Ashman LK, O'Keefe DE, Juttner CA, Toogood IRG, Rice MS (1986) Autologous responses to human leukaemic cells in mixed leucocyte culture. Cancer Immunol Immunother 22:95–99
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick MR, Sultan C (1976) Proposals for the classification of the acute leukaemias. Br J Haematol 33:451–458
Bevan MJ (1975) The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med 142:1349–1364
Bradley TR, Pilkington G, Garson M, Hodgson GS, Kraft N (1982) Cell lines derived from a human myelomonocytic leukaemia. Br J Haematol 51:595–604
Brooks DA, Zola H, McNamara PJ, Bradley J, Bradstock KF, Hancock WW, Atkins RC (1983) Membrane antigens of human cells of the monocyte/macrophage lineage: studies with monoclonal antibodies. Pathology 15:45–52
Fellous M, Kamoun M, Weils J, Dausset J, Clements G, Zeuthen J, Klein G (1977) Induction of HLA expression in Daudi cells after cell fusion. Immunogenetics 5:423–436
Furukawa Y, Ohta M, Miura Y, Saito M (1987) Interleukin-1 producing ability of leukaemia cells and its relationship to morphological diagnosis. Br J Haematol 65:11–15
Gadd SJ, Ashman LK (1983) Binding of mouse monoclonal antibodies to human leukaemic cells via the Fc receptor: a possible source of “false positive” reactions in specificity screening. Clin Exp Immunol 54:811–818
Gery I, Lepe-Zuniga JL (1984) Interleukin 1: Uniqueness of its production and spectrum of activities. In: Pick E (ed) Lymphokines, vol 9. Academic Press, Orlando, pp 109–125
Giannoulis N, Ogier C, Hast R, Lindblom B, Sjögren AM, Reizenstein P (1984) Difference between young and old patients in characteristic of leukaemic cells: older patients have cells growing excessively in vitro, with low antigenicity despite high HLA-DR antigens. Am J Hematol 16:113–121
Gillis S, Watson J (1980) Biochemical and biological characterization of lymphocyte regulatory molecules. V Identification of an interleukin 2-producing human leukaemia T cell line. J Exp Med 152:1709–1719
Gordon RD, Simpson E, Samelson LE (1975) In vitro cell mediated immune responses to the male specific (H-Y) antigen in mice. J Exp Med 142:1108–1120
Janeway CA, Bottomly K, Babich J, Conrad P, Conzen S, Jones B, Kaye J, Katz M, McVay L, Murphy DB, Tite J (1984) Quantitative variation in Ia antigen expression plays a central role in immune regulation. Immunol Today 5:99–105
Krensky AM, Sanchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ (1983) The functional significance, distribution and structure of LFA-1, LFA-2 and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol 131:611–616
Kurt-Jones EA, Beller DI, Mizel SB, Unanue ER (1985) Identification of membrane-associated interleukin-1 in macrophages. Proc Natl Acad Sci USA 82:1204–1208
Lachman LB, Moore JO, Metzgar RS (1978) Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukaemia cells. Cell Immunol 41:199–206
Lachman LB, Shih LCN, Brown DC (1985) Interleukin 1 from human leukaemic monocytes. In: Di Sabato G, Langone JJ, Van Vunakis J (eds) Methods Enzymol Vol 116. Academic Press, Orlando, pp 467–479
Lafferty KJ, Andrus L, Prowse SJ (1980) Role of lymphokine and antigen in the control of specific T cell responses. Immunol Rev 51:279–314
Lafferty KJ, Prowse SJ, Simeonovic CJ (1983) Immunobiology of tissue transplantation: a return to the passenger leucocyte concept. Ann Rev Immunol 1:143–173
Lozzio BB, Lozzio CB (1979) Properties and usefulness of the original K-562 human myelogenous leukaemia cell line. Leuk Res 3:363–370
Madsen M, Johnsen HE, Wendleboe Hansen P, Christiansen SE (1980) Isolation of human T and B lymphocytes by E-rosette gradient centrifugation. Characterization of the isolated subpopulations. J Immunol Methods 33:323
Miale TD, Stenke LAL, Lindblom JB, Sjögren A-M, Reizenstein PG, Uden A-M, Lawson DL (1982) Surface Ia-like expression and MLR stimulating capacity of human leukemic myeloblasts: implications for immunotherapy and prognosis. Acta Haematol 68:3–13
Mizel SB (1982) Interleukin 1 and T cell activation. Immunol Rev 63:51–72
O'Connor CG, Ashman LK (1982) Application of the nitrocellulose transfer technique and alkaline phosphatase conjugated anti-immunoglobulin for determination of the specificity of monoclonal antibodies to protein mixtures. J Immunol Methods 54:267–271
O'Keefe DE, Ashman LK (1982) Peanut agglutinin. A marker for normal and leukaemic cells of the monocyte lineage. Clin Exp Immunol 48:329–338
O'Keefe DE, Ashman LK (1982) Variation in accessory cell requirements in human mixed lymphocyte response to leukaemic cell lines. Immunology 47:633–641
Oppenheim JJ, Shneyour A, Kook AI (1976) Enhancement of DNA synthesis and cAMP content of mouse thymocytes by mediator(s) derived from adherent cells. J Immunol 116:1466–1472
Palacios R (1982) Mechanism of T cell activation: role and functional relationships of HLA-DR antigens and interleukins. Immunol Rev 63:73–110
Pfizenmaier K, Pan SH, Knowles BB (1980) Preferential H-2 association in cytotoxic T cell response to SV40 tumour-associated specific antigens. J Immunol 124:1888–1891
Rabin J, Hopkins RF, Ruscetti FW, Neubauer RH, Brown RL, Kawakami TG (1981) Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J Immunol 127:1852–1856
Reinherz EL, Meuer SC, Schlossman SF (1983) The human T cell receptor: analysis with cytotoxic T cell clones. Immunol Rev 74:81–112
Siegel S (1956) Nonparametric statistics for the behavioural sciences (International Student edn). McGraw-Hill, Kogakusha, Tokyo
Taylor GM, Fergusson W, Dyer PA, Harris R, Morrell G (1983) An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses. Cancer Immunol Immunother 16:117–122
White DL, Ashman LK, Dart GW, Zola H, Toogood IRG, Kimber RJ (1987) The expression of mature myeloid cell differentiation markers in acute leukaemia. Pathology 19:137–142
Zola H, McNamara PJ, Moore HA, Smart IJ, Brooks DA, Beckman IGR, Bradley J (1983) Maturation of human B lymphocytes — studies with a panel of monoclonal antibodies against membrane antigens. Clin Exp Immunol 52:655
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ashman, L.K., Kriek, G.W., Cooper, S.J. et al. Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells. Cancer Immunol Immunother 25, 250–256 (1987). https://doi.org/10.1007/BF00199155
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199155